ViennaLab Diagnostics GmbH aus Vienna auf der MEDICA 2017 in Düsseldorf -- COMPAMED Messe
Hersteller

ViennaLab Diagnostics GmbH

Gaudenzdorfer Guertel 43-45, 1120 Vienna
Österreich

Telefon +43 1 8120156
Fax +43 1 8120156-19
info@viennalab.com

Dieser Aussteller ist Mitaussteller von
ADVANTAGE AUSTRIA Wirtschaftskammer Österreich

Hallenplan

MEDICA 2017 Hallenplan (Halle 3): Stand F56

Geländeplan

MEDICA 2017 Geländeplan: Halle 3

Unser Angebot

Produktkategorien

  • 03  Diagnostika
  • 03.01  Klinische Chemie
  • 03.01.02  DNA Diagnose Kits

DNA Diagnose Kits

  • 03  Diagnostika
  • 03.01  Klinische Chemie
  • 03.01.07  Gentests / Molekularbiologische Diagnostik

Gentests / Molekularbiologische Diagnostik

  • 03  Diagnostika
  • 03.01  Klinische Chemie
  • 03.01.07  Gentests / Molekularbiologische Diagnostik
  • 03.01.07.02  DNA-Analytik

DNA-Analytik

  • 03  Diagnostika
  • 03.02  Immunochemie (Immunologie)
  • 03.02.16  Therapeutische Medikamentenüberwachung

Therapeutische Medikamentenüberwachung

  • 03  Diagnostika
  • 03.02  Immunochemie (Immunologie)
  • 03.02.16  Therapeutische Medikamentenüberwachung
  • 03.02.16.01  Diagnostika / Kits für die Pharmaka-Bestimmung

Diagnostika / Kits für die Pharmaka-Bestimmung

  • 03  Diagnostika
  • 03.02  Immunochemie (Immunologie)
  • 03.02.17  Tumormarker

Tumormarker

  • 03  Diagnostika
  • 03.02  Immunochemie (Immunologie)
  • 03.02.17  Tumormarker
  • 03.02.17.01  Diagnostika / Kits für die Tumormarker-Bestimmung

Diagnostika / Kits für die Tumormarker-Bestimmung

Über uns

Firmenporträt

ViennaLab Diagnostics, an Austrian company, has been successful in developing, manufacturing and worldwide distributing genetic tests since its foundation in 1990.

ViennaLab StripAssays® and RealFast™ Assays are easy, reliable and affordable human in vitro diagnostic tests covering the following fields: Inherited Diseases, Genetic Predispositions, Pharmacogenetics and Oncology.

Assays are offered for Cardio-Vascular Diseases, Thalassemias, Cystic Fibrosis, Familial Mediterranean Fever, Alzheimer Disease, Sugar Intolerance, among others. Products of the pharmacogenetics and oncology portfolio help to achieve safer and more individualized anticoagulant and cancer therapies.

Based on polymerase chain reaction (PCR) and reverse hybridization, the well-established and user-friendly StripAssays® accomplish up to 48 immobilized probes for wild-type and mutated alleles. StripAssays® require standard laboratory equipment, making them very easy to implement. For high-volume users, automation of the entire teststrip processing is available. StripAssay® results can be either read by eye or interpreted with a proprietary scanner-based software (Evaluator).

RealFast™ Assays are based on TaqMan® real-time PCR technology and allow the rapid and reliable detection of single nucleotide polymorphisms (SNPs) as well as copy number variations (CNVs).

All ViennaLab products are CE/IVD marked and manufactured according to the quality standards of ISO 9001 and ISO 13485. StripAssays® and RealFast™ Assays also regularly participate in international research studies and in external quality assessment (EQA) schemes, which allow scientific evidence of the quality employed.

To find out more, please visit www.viennalab.com.

Mehr Weniger

Unternehmensdaten

Anzahl der Beschäftigten

20-49

Gründungsjahr

1990

Geschäftsfelder

Diagnostika